• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗南部设拉子膀胱癌的流行病学状况

Epidemiologic status of bladder cancer in Shiraz, southern Iran.

作者信息

Salehi Alireza, Khezri Abdul-aziz, Malekmakan Leila, Aminsharifi Alireza

机构信息

Epidemiology Department, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Asian Pac J Cancer Prev. 2011;12(5):1323-7.

PMID:21875290
Abstract

BACKGROUND

Bladder cancer is the second most common malignancy of the genitourinary tract worldwide after prostate cancer. However, in Iran it is the most common cancer of the genitourinary system and the third most common cancer in males. The increasing trend in bladder cancer incidence in recent decades, along with the lack of research on this malignancy in Iran, make epidemiologic research important in light of its preventability through early recognition and limiting exposure to risk factors. The present study aimed to assess the epidemiology of bladder cancer in Shiraz, a large city in southern Iran, during a 2-year period.

METHODS

The data for this study were obtained from the population-based cancer registry of the Vice-Chancellery for Health Affairs of Shiraz University of Medical Sciences and Shiraz hospitals between March 1, 2007 and March 1, 2009. Demographic, clinical and pathological aspects of 216 patients with bladder cancer were investigated through careful review of their medical records. Statistical analyses were performed with SPSS software. P values less than 0.05 were considered statistically significant.

RESULTS

We analyzed data for 179 (82.9%) men and 37 (17.1%) women (mean age of 65.1∓12.7 years). Tobacco and opium use were found in 109 (65.3%) and 44 (34.1%) patients, respectively. Cigarette smokers and water pipe smokers were mostly men (P=0.001 and P=0.04, respectively). The most common type of tumor was transitional cell carcinoma (95.7%) and most tumors were of low malignant potential grade (39.7%). Nearly half of the patients suffered recurrence.

CONCLUSION

Comparisons with previous studies showed that bladder cancer tends to appear slightly more often in the elderly and that the tumors tend to have a higher grade of malignancy in our region. There is a need for more epidemiologic studies on the trends in the incidence and other epidemiologic indices.

摘要

背景

膀胱癌是全球仅次于前列腺癌的第二大常见泌尿生殖系统恶性肿瘤。然而,在伊朗,它是泌尿生殖系统最常见的癌症,也是男性中第三大常见癌症。近几十年来膀胱癌发病率呈上升趋势,且伊朗缺乏对这种恶性肿瘤的研究,鉴于其可通过早期识别和限制危险因素暴露来预防,因此流行病学研究具有重要意义。本研究旨在评估伊朗南部大城市设拉子在两年期间膀胱癌的流行病学情况。

方法

本研究的数据来自设拉子医科大学卫生事务副校长办公室和设拉子医院基于人群的癌症登记处,时间跨度为2007年3月1日至2009年3月1日。通过仔细查阅216例膀胱癌患者的病历,对其人口统计学、临床和病理方面进行了调查。使用SPSS软件进行统计分析。P值小于0.05被认为具有统计学意义。

结果

我们分析了179名(82.9%)男性和37名(17.1%)女性的数据(平均年龄65.1±12.7岁)。分别有109例(65.3%)和44例(34.1%)患者有吸烟和吸食鸦片史。吸烟者和水烟吸食者大多为男性(P值分别为0.001和0.04)。最常见的肿瘤类型是移行细胞癌(95.7%),且大多数肿瘤为低恶性潜能分级(39.7%)。近一半的患者出现复发。

结论

与先前研究相比,表明膀胱癌在老年人中出现的频率略高,且我们地区的肿瘤恶性程度往往更高。需要对发病率趋势和其他流行病学指标进行更多的流行病学研究。

相似文献

1
Epidemiologic status of bladder cancer in Shiraz, southern Iran.伊朗南部设拉子膀胱癌的流行病学状况
Asian Pac J Cancer Prev. 2011;12(5):1323-7.
2
Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, northern Iran.伊朗北部马赞德兰省膀胱癌的流行病学和社会经济状况
Asian Pac J Cancer Prev. 2012;13(10):5053-6. doi: 10.7314/apjcp.2012.13.10.5053.
3
A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003).伊朗一家医院膀胱癌的描述性回顾性研究(1973 - 2003年)
Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):681-4.
4
Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.鸦片作为膀胱癌的一个风险因素:伊朗一项基于人群的病例对照研究。
Arch Iran Med. 2015 Sep;18(9):567-71.
5
Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.初次就诊时重度吸烟与侵袭性膀胱癌
Urology. 2015 Nov;86(5):968-72. doi: 10.1016/j.urology.2015.05.040. Epub 2015 Jul 17.
6
Clinical-pathological differences and smoking habit depending on gender in a cohort of patients with transitional cell carcinoma of the bladder: retrospective study.膀胱癌移行细胞癌患者队列中临床病理差异及吸烟习惯与性别的关系:回顾性研究
Arch Esp Urol. 2011 Jun;64(5):427-33.
7
Opium: a potential urinary bladder carcinogen in man.鸦片:对人类而言的一种潜在膀胱致癌物。
Cancer. 1979 Jun;43(6):2315-21. doi: 10.1002/1097-0142(197906)43:6<2315::aid-cncr2820430622>3.0.co;2-j.
8
Prominent bladder cancer risk factors in Iran.伊朗膀胱癌的主要风险因素。
Asian Pac J Cancer Prev. 2010;11(3):601-6.
9
Cancer of the bladder in Southern Iran.伊朗南部的膀胱癌
Cancer. 1978 Jul;42(1):353-6. doi: 10.1002/1097-0142(197807)42:1<353::aid-cncr2820420153>3.0.co;2-w.
10
Carcinoma of the urinary bladder in a tertiary care setting in a developing country.发展中国家三级医疗机构中的膀胱癌
Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):449-52.

引用本文的文献

1
Prevalence of tobacco use among cancer patients in Iran: a systematic review and meta-analysis.伊朗癌症患者的烟草使用流行率:系统评价和荟萃分析。
BMC Public Health. 2024 Apr 18;24(1):1081. doi: 10.1186/s12889-024-18594-8.
2
Five Common Cancers in Iran in 2019: Secondary Analysis to Discovering Cluster of Cancers.2019 年伊朗的五种常见癌症:二次分析以发现癌症集群。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231186923. doi: 10.1177/21501319231186923.
3
Epidemiologic Profile of Microscopic Hematuria in Iran: A Systematic Review and Meta-Analysis.
伊朗镜下血尿的流行病学概况:一项系统评价与荟萃分析
Iran J Public Health. 2022 Oct;51(10):2194-2206. doi: 10.18502/ijph.v51i10.10978.
4
Estimating the Prevalence of Bladder Cancer by Stage in Iran as a Developing Country.作为一个发展中国家,伊朗膀胱癌各阶段患病率的估算。
Med J Islam Repub Iran. 2022 Apr 18;36:37. doi: 10.47176/mjiri.36.37. eCollection 2022.
5
Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.多组学揭示 SRC 蛋白表达在膀胱癌中的新型预后意义及其与免疫治疗反应的相关性。
Ann Med. 2021 Dec;53(1):596-610. doi: 10.1080/07853890.2021.1908588.
6
Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013-2018): a population-based study.库尔德斯坦省膀胱癌患者的生存率及其相关因素(2013-2018):一项基于人群的研究。
BMC Urol. 2020 Dec 11;20(1):195. doi: 10.1186/s12894-020-00769-1.
7
Gene Polymorphisms Are Associated with Urinary Bladder Cancer in an Iranian Population.基因多态性与伊朗人群的膀胱癌相关。
Rep Biochem Mol Biol. 2019 Jul;8(2):194-199.
8
A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.伊朗结直肠癌、肺癌、肝癌、甲状腺癌和膀胱癌的发病率及死亡率综述,并与其他国家进行比较。
Contemp Oncol (Pozn). 2019;23(1):7-15. doi: 10.5114/wo.2019.84112. Epub 2019 Apr 5.
9
Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.伊朗东南部克尔曼省膀胱癌的流行病学与住院费用
Iran J Public Health. 2018 Apr;47(4):567-574.
10
Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.水飞蓟宾通过下调肌动蛋白细胞骨架和PI3K/Akt信号通路抑制膀胱癌。
Oncotarget. 2017 Sep 8;8(54):92032-92042. doi: 10.18632/oncotarget.20734. eCollection 2017 Nov 3.